LUPINPharmaceuticals

Lupin LtdProfit & Loss Statement

2313.90
-0.66%

Lupin Ltd Profit & Loss Statement (Annual)

Metric20252024202320222021
Tax Effect Of Unusual Items-33.58 Cr-33.70 Cr-5.59 Cr-586.39 Cr
Tax Rate For Calcs0.180.200.380.30
Normalized EBITDA5.65K Cr4.07K Cr1.85K Cr2.35K Cr
Total Unusual Items-190.22 Cr-167.72 Cr-14.91 Cr-1.95K Cr
Total Unusual Items Excluding Goodwill-190.22 Cr-167.72 Cr-14.91 Cr-1.95K Cr
Net Income From Continuing Operation Net Minority Interest3.28K Cr1.91K Cr430.08 Cr-1.53K Cr
Reconciled Depreciation1.17K Cr995.56 Cr880.69 Cr1.66K Cr
Reconciled Cost Of Revenue7.46K Cr7.15K Cr7.26K Cr7.09K Cr
EBITDA5.45K Cr3.90K Cr1.84K Cr393.76 Cr
EBIT4.29K Cr2.70K Cr956.70 Cr-1.26K Cr
Net Interest Income-165.02 Cr-265.38 Cr-241.87 Cr-109.96 Cr
Interest Expense270.53 Cr279.04 Cr240.21 Cr107.26 Cr
Interest Income129.85 Cr46.23 Cr32.43 Cr32.81 Cr
Normalized Income3.44K Cr2.05K Cr439.40 Cr-159.78 Cr
Net Income From Continuing And Discontinued Operation3.28K Cr1.91K Cr430.08 Cr-1.53K Cr
Total Expenses17.85K Cr16.86K Cr15.38K Cr15.64K Cr
Rent Expense Supplemental85.62 Cr69.69 Cr70.27 Cr68.08 Cr
Diluted Average Shares45.78 Cr45.72 Cr45.69 Cr45.52 Cr
Basic Average Shares45.61 Cr45.52 Cr45.47 Cr45.40 Cr
Diluted EPS71.6941.879.41-33.65
Basic EPS71.9542.059.46-33.65
Diluted NI Availto Com Stockholders3.28K Cr1.91K Cr430.08 Cr-1.53K Cr
Net Income Common Stockholders3.28K Cr1.91K Cr430.08 Cr-1.53K Cr
Otherunder Preferred Stock Dividend0.000.000.000.00
Net Income3.28K Cr1.91K Cr430.08 Cr-1.53K Cr
Minority Interests-24.64 Cr-21.09 Cr-17.61 Cr-18.68 Cr
Net Income Including Noncontrolling Interests3.31K Cr1.94K Cr447.69 Cr-1.51K Cr
Net Income Continuous Operations3.31K Cr1.94K Cr447.69 Cr-1.51K Cr
Tax Provision708.74 Cr486.70 Cr268.80 Cr137.15 Cr
Pretax Income4.01K Cr2.42K Cr716.49 Cr-1.37K Cr
Other Non Operating Income Expenses19.23 Cr48.22 Cr6.28 Cr73.04 Cr
Special Income Charges-236.68 Cr-192.21 Cr-28.39 Cr-1.99K Cr
Other Special Charges232.50 Cr192.02 Cr24.96 Cr1.99K Cr
Write Off4.18 Cr0.19 Cr3.43 Cr4.62 Cr
Impairment Of Capital Assets120.90 Cr201.25 Cr0.00
Net Non Operating Interest Income Expense-165.02 Cr-265.38 Cr-241.87 Cr-109.96 Cr
Total Other Finance Cost24.34 Cr32.57 Cr34.09 Cr35.51 Cr
Interest Expense Non Operating270.53 Cr279.04 Cr240.21 Cr107.26 Cr
Interest Income Non Operating129.85 Cr46.23 Cr32.43 Cr32.81 Cr
Operating Income4.35K Cr2.80K Cr889.44 Cr550.60 Cr
Operating Expense10.39K Cr9.71K Cr8.12K Cr8.55K Cr
Other Operating Expenses2.65K Cr2.49K Cr2.04K Cr1.89K Cr
Depreciation And Amortization In Income Statement1.17K Cr1.20K Cr880.69 Cr1.66K Cr
Depreciation Income Statement1.17K Cr1.20K Cr880.69 Cr1.66K Cr
Selling General And Administration2.80K Cr2.60K Cr2.12K Cr1.90K Cr
Selling And Marketing Expense1.27K Cr1.22K Cr1.08K Cr981.19 Cr
General And Administrative Expense1.53K Cr1.39K Cr1.05K Cr915.43 Cr
Rent And Landing Fees85.62 Cr69.69 Cr70.27 Cr68.08 Cr
Gross Profit14.74K Cr12.51K Cr9.01K Cr9.10K Cr
Cost Of Revenue7.46K Cr7.15K Cr7.26K Cr7.09K Cr
Total Revenue22.19K Cr19.66K Cr16.27K Cr16.19K Cr
Operating Revenue22.19K Cr19.66K Cr16.27K Cr16.19K Cr
Net Income Discontinuous Operations0.00

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.